Approval · Notice of Compliance 963 · 2000
AMPHOTEC: Notice of Compliance 963
Issued April 26, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 963
- Date
- April 26, 2000
- Company
- Sequus Pharmaceuticals Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antifungal agent
Products in this notice
Medicinal ingredients
- AMPHOTERICIN B 50 MG per VIAL
- AMPHOTERICIN B 100 MG per VIAL